| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8286169 | Parkinsonism & Related Disorders | 2014 | 32 Pages |
Abstract
Rotigotine was well tolerated at doses up to 16Â mg/24Â h and showed similar efficacy to ropinirole except that the application site reaction was much higher in the rotigotine group.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Yoshikuni Mizuno, Masahiro Nomoto, Kazuko Hasegawa, Nobutaka Hattori, Tomoyoshi Kondo, Miho Murata, Masahiro Takeuchi, Masayoshi Takahashi, Takayuki Tomida, on behalf of the Rotigotine Trial Group on behalf of the Rotigotine Trial Group,